Evidence map›Paper›PMID 28392297›Full record

ArticleNeuroscience2017

Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain.

Stefanie L Ritter-Makinson, Maryse Paquet, James W Bogenpohl, Rachel E Rodin, C Chris Yun, Edward J Weinman, Yoland Smith, Randy A Hall

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Metabotropic glutamate receptor trafficking.Molecular and cellular neurosciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Stefanie L Ritter-MakinsonDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Maryse PaquetDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
James W BogenpohlYerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Rachel E RodinDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
C Chris YunDepartment of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA 30329, USA.
Edward J WeinmanDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Yoland SmithYerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Randy A HallDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: rhall3@emory.edu.
Emory University · USUniversity of Maryland, Baltimore · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Regulation of NHE3 by glucocorticoids, SGK1 and NHERF2R01DK061418 · NIDDK · EMORY UNIVERSITY · PI YUN, CHANGHYON CHRIS · 2003 to 2015
$4.0M
Training In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9M
PDZ scaffold regulation of astrocytic glutamate receptors and transportersR01NS055179 · NINDS · EMORY UNIVERSITY · PI HALL, RANDY A. · 2008 to 2012
$1.5M
Astrocytic Scaffold Regulation of the Metabotropic Glutamate Receptor 3F31MH086186 · NIMH · EMORY UNIVERSITY · PI RITTER-MAKINSON, STEFANIE LEIGH · 2010 to 2012
$61k
Regulation of intestinal homeostasis and epithelial barrier by LPAI01BX002540 · VA · VETERANS HEALTH ADMINISTRATION · PI YUN, CHANGHYON CHRIS · 2015 to 2018
–
BLRD VA I01 BX002540NIDDK NIH HHS R01 DK061418NIGMS NIH HHS T32 GM007753NIH HHS P51 OD011132NIMH NIH HHS F31 MH086186NINDS NIH HHS R01 NS055179NINDS NIH HHS T32 NS096050
6 · The paper itself

Abstract

The group II metabotropic glutamate receptors mGluR2 and mGluR3 are key modulators of glutamatergic neurotransmission. In order to identify novel Group II metabotropic glutamate receptor (mGluR)-interacting partners, we screened the C-termini of mGluR2 and mGluR3 for interactions with an array of PDZ domains. These screens identified the Na+/H+ exchanger regulatory factors 1 and 2 (NHERF-1 & -2) as candidate interacting partners. Follow-up co-immunoprecipitation studies demonstrated that both mGluR2 and mGluR3 can associate with NHERF-1 and NHERF-2 in a cellular context. Functional studies revealed that disruption of PDZ interactions with mGluR2 enhanced receptor signaling to Akt. However, further studies of mGluR2 and mGluR3 signaling in astrocytes in which NHERF expression was reduced by gene knockout (KO) and/or siRNA knockdown techniques revealed that the observed differences in signaling between WT and mutant mGluR2 were likely not due to disruption of interactions with the NHERF proteins. Electron microscopic analyses revealed that Group II mGluRs were primarily expressed in glia and unmyelinated axons in WT, NHERF-1 and NHERF-2 KO mice, but the relative proportion of labeled axons over glial processes was higher in NHERF-2 KO mice than in controls and NHERF-1 KO mice. Interestingly, our anatomical studies also revealed that loss of either NHERF protein results in ventriculomegaly, which may be related to the high incidence of hydrocephaly that has previously been observed in NHERF-1 KO mice. Together, these studies support a role for NHERF-1 and NHERF-2 in regulating the distribution of Group II mGluRs in the murine brain, while conversely the effects of the mGluR2/3 PDZ-binding motifs on receptor signaling are likely mediated by interactions with other PDZ scaffold proteins beyond the NHERF proteins.

Indexed as

AnimalsAstrocytesBrainHEK293 CellsHumansMice, Inbred C57BLMice, KnockoutNerve Fibers, UnmyelinatedPDZ DomainsPhosphoproteinsProto-Oncogene Proteins c-aktReceptors, Metabotropic GlutamateSodium-Hydrogen Exchangersmetabotropic glutamate receptor 2metabotropic glutamate receptor 3PhosphoproteinsProto-Oncogene Proteins c-aktReceptors, Metabotropic Glutamatesodium-hydrogen exchanger regulatory factorSodium-Hydrogen Exchangersastrocyteaxonelectron microscopyknockout micepre-synapticprotein–protein interaction

Identifiers

PMID28392297
PMCPMC5503475
OpenAlexW2604980245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.